Cite
HARVARD Citation
Goyal, L. et al. (2017). A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Cancer. 123 (11), pp. 1979-1988. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goyal, L. et al. (2017). A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Cancer. 123 (11), pp. 1979-1988. [Online].